Lifeway Foods (LWAY) Q3 2024 earnings summary

Executive summary

• Net sales for Q3 2024 increased 12.7% year-over-year to $46.1 million, marking the second-highest quarterly net sales ever and 20 consecutive quarters of growth, driven by flagship Drinkable Kefir and product innovation.

• Year-to-date net sales rose 18.5% to $139.9 million compared to the first nine months of 2023.

• Net income for Q3 2024 was $3 million, with EPS of $0.20 basic and $0.19 diluted.

• The company expanded distribution into South Africa, Dubai, and the UAE, and launched 100% lactose-free organic whole milk Flavor Fusion products with reduced sugar.

• An unsolicited $25/share acquisition proposal from Danone was rejected as undervaluing the company; a shareholder rights plan was adopted.

Financial highlights

• Gross profit margin for Q3 2024 was 25.7%; year-to-date margin at 26.2%, up 30 basis points year-over-year.

• Net income for Q3 2024 was $3 million, with EPS of $0.20 basic and $0.19 diluted, compared to $0.23 for both in Q3 2023.

• Operating income for Q3 2024 was $4.2 million, down from $5.0 million in Q3 2023.

• Cash and cash equivalents increased to $20.6 million as of September 30, 2024, from $13.2 million at year-end 2023.

• Capital spending increased by $2.2 million to $5.4 million for the nine months ended September 30, 2024.

Outlook and guidance

• On track to set a new annual sales record, with confidence in continued sales momentum and ongoing investments in manufacturing, marketing, and product innovation.

• Management expects health and wellness trends to continue supporting growth in premium product lines.

• Sufficient liquidity is expected to fund working capital, capital requirements, and growth initiatives.